A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

British Journal of Cancer

Volumn 96, Issue 6, 2007, Pages 912-917

  Willeke, F ^a   Horisberger, K ^a   Kraus Tiefenbacher, U ^a   Wenz, F ^a   Leitner, A ^a   Hochhaus, A ^a   Grobholz, R ^b   Willer, A ^a   Kahler G ^a   Post, S ^a   Hofheinz, R D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Capecitabine; Chemoradiotherapy; Irinotecan; Locally advanced rectal cancer

Indexed keywords

AMINOTRANSFERASE; CAPECITABINE; DEXAMETHASONE; FLUOROURACIL; IRINOTECAN; SEROTONIN 3 ANTAGONIST;

ABDOMINAL CRAMP; ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ANUS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHOLINERGIC SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE COURSE; DRUG WITHDRAWAL; ENZYME ACTIVITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HAND FOOT SYNDROME; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; INTERMETHOD COMPARISON; LEUKOPENIA; LOW DRUG DOSE; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROCTITIS; RADIATION DERMATITIS; RADIATION DOSE; RECTUM CANCER; RECTUM SURGERY; SEPSIS; SIDE EFFECT; STOMATITIS; SURGICAL APPROACH; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS;

EID: 33947425624     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603645     Document Type: Article

References (22)

1. André C, Boni C, Mounedij-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351
2. Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, Colette L (2005) Preoperative radiation (Preop RT) in rectal cancer: effect and timing of additional chemotherapy (CT). 5-year results of the EORTC 22921 trial. Proc Am Soc Clin Oncol 23: 3505 (abstract)
3. Compton CC, for the members of the Cancer Committee, College of American Pathologists (2000) Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumours, lymphomas, sarcomas, and tumours of the vermiform appendix. A basis for checklists. Arch Pathol Lab Med 124: 1016-1025
4. Gerard JP, Bonnetain F, Conroy T, Chapet O, Bouche O, Closon-Dejardin M, Untereiner M, Leduc B, Francois E, Bedenne L (2005) Preoperative (preop) radiotherapy (RT) +/- 5-FU/folinic acid (FA) in T3-4 rectal cancers: results of the FFCD 9203 trial. Proc Am Soc Clin Oncol 23: 3504 (abstr.)
5. Glynne-Jones R, Dunst J, Sebag-Montefiore D (2006) The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how succesful have we been? Ann Oncol 17: 361-371
6. Gollins SW, Myint S, Levine E, Bishop J, Haylock B, Susnerwala S, Saunders M, Biswas A (2006) Radiotherapy plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer: A phase I/II study. Proc Am Soc Clin Oncol 24: 13519 (abstr.)
7. Hartley A, Ho KF, McConkey C, Geh JI (2005) Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 78: 934-938
8. Hofheinz R-D, von Gerstenberg-Helldorf B, Wenz F, Gnad U, Kraus-Tiefenbacher U, Müldner A, Hehlmann R, Post S, Hochhaus A, Willeke F (2005) Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 23: 1350-1357
9. Kapiteijn E, Marijnen C, Nagtegaal I, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345: 638-646
10. Klautke G, Kirchner R, Hopt U, Prall F, Foitzik T, Fietkau R (2005) Continuous infusion of 5-FU and weekly irinotecan with concurrent radiotherapy as neoadjuvant treatment for locally advanced or recurrent rectal cancer. Br J Cancer 92: 1215-1220
11. Klautke G, Kuchenmeister U, Foitzik T, Ludwig K, Prall F, Klar E, Fietkau R (2006) Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer 94: 976-981
12. Köhne CH, van Cutsem E, Wils J, Bokemeyer C, El-Serafi M, Lutz MP, Lorenz M, Reichardt P, Ruckle-Lanz H, Frickhofen N, Fuchs R, Mergenthaler HG, Langenbuch T, Vanhoefer U, Rougier P, Voigtmann R, Muller L, Genicot B, Anak O, Nordlinger B, European Organisation for Research and Treatment of cancer Gastrointestinal Study Group (2005) Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol 23: 4856-4865
13. Machiels JP, Duck L, Honhon B, Coster B, Coche JC, Scalliet P, Humblet Y, Aydin S, Kerger J, Remopuchamps V, Canon JL, van Maele P, Gilbeau L, Laurent S, Kirkove C, Octave-Prignot M, Baurain JF, Kartheuser A, Sempoux C (2005) Phase II study of preoperative oxaliplatin, capecitabina and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol 16: 1898-1905
14. Mitchell EP (2000) Irinotecan in preoperative combined-modality therapy for locally advanced rectal cancer. Oncology (Huntingt) 14(Suppl 14): 56-59
15. Privitera G, Spatola C, Acquaviva G, Di Franco I, Raffaele L, Salamone V, Ettorre GC (2006) Neoadjuvant Xelox vs Xeliri in combination with concomitant boost 3D-conformal radiotherapy in locally advanced rectal cancer (LARC). Proc Am Soc Clin Oncol 24: 3570 (abstract)
16. Rödel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C (2005) Prognostic significance of tumour regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23: 8688-8696
17. Roh MS, Colangelo L, Wieand S, O'Connell M, Petrelli N, Smith R, Mamounas E, Hyams D, Wolmark N (2004) Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. Proc Am Soc Clin Oncol 22: 3505 (abstract)
18. Rutten H, Sebag-Montefiore D, Glynne-Jones R, Rullier E, Peeters M, Brown G, van Cutsem E, Ricci S, van de Velde C, Quirke P (2006) Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: results of an international multicenter phase II study. Proc Am Soc Clin Oncol 24: 3528 (abstract)
19. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative vs postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740
20. Sebag-Montefiore D, Steele R, Quirke P, Grieve R, Khanna S, Monson J, Holliday A, Thomson L, Griffith G, Stephens R, for the NCRI colorectal cancer study group and CRO 7 participants (2006) Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer. Preliminary results of the MRC CR07 randomised trial. Proc Am Soc Clin Oncol 24: 3511 (abstract)
21. van Cutsem E, Labianca R, Hossfeld D, Bodoky G, Roth A, Aranda E, Nordlinger B, Assadourian S, Wang K, Cunningham D (2005) Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) vs 5-FU/FA (F) in stage III colon cancer patients (pts) (PETACC 3). Proc Am Soc Clin Oncol 23: 8 (abstract)
22. Wolmark N, Wieand HS, Kuebler JP, Colangelo L, Smith RE (2005) A phase III trial comparing FULV to FULV+oxaliplatin in stage II or III carcinoma of the colon: Results of NSABP Protocol C-07. Proc Am Soc Clin Oncol 23: 3500 (abstract)